Acetazolamide-induced	acetazolamide-induced	O	O
nephrolithiasis	nephrolithiasis	O	S_disease
:	:	O	O
implications	implications	O	O
for	for	O	O
treatment	treatment	O	O
of	of	O	O
neuromuscular	neuromuscular	O	B_disease
disorders	disorders	O	I_disease
.	.	O	O

Carbonic	carbonic	B_chemical	O
anhydrase	anhydrase	I_chemical	O
inhibitors	inhibitors	I_chemical	O
can	can	O	O
cause	cause	O	O
nephrolithiasis	nephrolithiasis	O	S_disease
.	.	O	O

We	we	O	O
studied	studied	O	O
20	20	O	O
patients	patients	O	O
receiving	receiving	O	O
long-term	long-term	O	O
carbonic	carbonic	B_chemical	O
anhydrase	anhydrase	I_chemical	O
inhibitor	inhibitor	O	O
treatment	treatment	O	O
for	for	O	O
periodic	periodic	O	O
paralysis	paralysis	O	S_disease
and	and	O	O
myotonia	myotonia	O	O
.	.	O	O

Three	three	O	O
patients	patients	O	O
on	on	O	O
acetazolamide	acetazolamide	S_chemical	O
(	(	O	O
15	15	O	O
%	%	O	O
)	)	O	O
developed	developed	O	O
renal	renal	O	O
calculi	calculi	O	O
.	.	O	O

Extracorporeal	extracorporeal	O	O
lithotripsy	lithotripsy	O	O
successfully	successfully	O	O
removed	removed	O	O
a	a	O	O
renal	renal	O	O
calculus	calculus	O	O
in	in	O	O
one	one	O	O
patient	patient	O	O
and	and	O	O
surgery	surgery	O	O
removed	removed	O	O
a	a	O	O
staghorn	staghorn	O	O
calculus	calculus	O	O
in	in	O	O
another	another	O	O
,	,	O	O
permitting	permitting	O	O
continued	continued	O	O
treatment	treatment	O	O
.	.	O	O

Renal	renal	O	O
function	function	O	O
remained	remained	O	O
normal	normal	O	O
in	in	O	O
all	all	O	O
patients	patients	O	O
.	.	O	O

Nephrolithiasis	nephrolithiasis	O	S_disease
is	is	O	O
a	a	O	O
complication	complication	O	O
of	of	O	O
acetazolamide	acetazolamide	S_chemical	O
but	but	O	O
does	does	O	O
not	not	O	O
preclude	preclude	O	O
its	its	O	O
use	use	O	O
.	.	O	O

